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ABSTRACT 
 
 
Shaj, Kavya. M.S., Department of Pharmacology and Toxicology, Wright State 
University, 2019. Differing functions of ATR kinase in human epidermal keratinocytes 
exposed to Ultraviolet B Radiation. 
 
 
Ataxia telangiectasia and Rad-3 related (ATR) is a DNA damage response protein 
kinase that is upregulated in various cancer cell types and has key roles in cell cycle 
progression, DNA repair and apoptosis. Small molecule ATR kinase inhibitors are of 
importance as antineoplastic agents because they sensitize cancer cells to DNA damaging 
chemotherapy drugs. However, only a few studies have looked at the effects of ATR kinase 
inhibitors on non-replicating cells, which constitute the majority of cells in the human body 
and have suggested an opposite, pro-apoptotic role for ATR kinase signaling in non-
replicating cells in comparison to a pro-survival function in replicating cells. Therefore, 
experimentations were conducted to explore this new role by using chemical inhibitors of 
ATR kinase in quiescent human keratinocytes in vitro and skin explants ex vivo irradiated 
with UVB. ATR kinase was activated in quiescent keratinocytes in DNA translocase and 
repair factor XPB-dependent manner whereas ATR inhibition reduced apoptotic signaling 
and apoptotic sunburn cells in Human skin epidermis. ATR kinase acutely protected the 
cells from DNA damage-induced cytotoxicity and cell death and upon cell cycle re-entry, 
conserves cell proliferation and limits mutagenesis at the hypoxanthine 
phosphoribosyltransferase locus. Loss of ATR kinase activated TLS polymerase dependent 
mutagenic Translesion DNA synthesis for gap filling followed by Nucleotide excision 
repair in quiescent keratinocytes exposed to DNA damaging UVB. In conclusion, these 
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results indicate that the ATR kinase has a pro-proliferative role in quiescent keratinocytes 
whereas it has pro-apoptotic role in human skin epidermis. It has important roles in 
promoting cell viability and proliferation and in preventing mutagenesis following UVB 
exposure even in cells that are not actively synthesizing DNA. Also, the mutagenic 
consequences of ATR inhibition in these cells have implications for the use of small 
molecule ATR kinase inhibitors in chemotherapy. 
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1. INTRODUCTION 
 
Ultraviolet radiation (UVR) emitted by the sun is a prevalent carcinogenic agent in 
the environment. While UVC (100-280nm) is absorbed by the ozone layer, most radiation 
in the UVA (315-400nm) and UVB (280-315) ranges reaches the earth.1 UVR can affect 
all organisms ranging from prokaryotes to mammals.2 Because of UVR’s low penetration, 
the organs most affected in humans are the skin and the eyes. Also, different UVR has 
different wavelength dependent penetration power within the different layers of the skin 
(Figure 1); Longer UVA penetrates the dermis generating reactive oxygen species that can 
indirectly affect the DNA. UVB is directly absorbed by DNA in epidermal cells thereby 
forming cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts (64PP) and UVC 
with shorter wavelengths and high energy are mostly absorbed by dead skin on surface.3  
 
Figure 1: Depth of penetration of different wavelengths of UV light into human skin. 
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UVR is the most prevalent DNA damaging agent in the environment. These damages 
in the DNA due to UVR interfere with the genomic integrity by misincorporation or 
modification of bases during replication, hydrolytic damage and/or oxidative damage due 
to free radicals and reactive oxygen species, single and double strand breaks (DSBs) and 
the formation of CPDs and 6-4 PPs lesions. In response to these damages, specific highly 
conserved repair mechanisms are initiated by the cells including nucleotide excision repair 
(NER), base excision repair (BER), mismatch repair (MMR), non-homologous end joining 
(NHEJ), homologous recombination (HR) repair and other additional responses like 
damage tolerance (dimer bypass), checkpoint activation, and programmed cell death or 
apoptosis. These cellular responses are collectively called as the DNA Damage Responses 
(DDR) (Figure 2) which detects the damage, activates signals to detect the damage and 
initiate repair.4-6 
1.1 DNA DAMAGE RESPONSE (DDR) MECHANISMS 
DNA damage in base pairing, called lesions formed due to genotoxins largely 
necessitates the DDR mechanisms in which some damages are removed directly via 
protein-mediated reversal whereas others are repaired by multiple protein-mediated 
catalytic processes leading to excision of bases and repair of the breaks formed on the DNA 
strands. Further, the multiple protein-mediated DDR mechanisms are specific to types of 
lesions and breaks formed on the DNA strand.5.6 DNA mismatches and insertion/deletion 
loops arising from DNA replication are detected and repaired by the mismatch repair 
(MMR) wherein single strand incision is mediated by nuclease, polymerase and ligase 
enzymes.6,7 Whereas, in base excision repair (BER), a DNA glycosylase enzyme initiates 
the removal of the damaged base before the single strand break repair is mediated by 
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nuclease, polymerase and ligase enzymes. The nucleotide excision repair (NER) 
recognizes helix-distorting UV induced lesions in two different manners: global genome 
NER (GG-NER) which scans the entire genome for distorting injury and transcription-
coupled repair (TC-NER) which specifically focuses on lesions blocking in RNA 
polymerase induced transcription. A notable aspect of NER is that the lesions are excised 
as a 22-30 base oligonucleotide resulting in single-stranded DNA (ssDNA) repair.6-9 In 
the case of double strand breaks ( DSBs) caused due to ionizing radiation (IR), two 
repair mechanism are involved: non-homologous end joining (NHEJ) and homologous 
recombination (HR). NHEJ occurs throughout the cell cycle whereas HR is restricted to 
only later S and G2 phase. In HR, the repair of DSBs and interstrand crosslinks is 
provided by recombination using a homologous template during DNA replication after 
recovery of stalled or broken replication forks whereas in NHEJ, re-ligation of damaged 
DNA strand does not require a homologous template for repair and therefore has a wide 
repair capacity to include any type of DNA ends.9-11 
 
Figure 2: DNA Damage and Repair Mechanisms 
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1.2 DNA DAMAGE SENSING KINASES AND CHECKPOINT REGULATION 
The ATM (ataxia-telangiectasia mutated), ATR (ATM- and Rad3-related), and DNA-
PKs (DNA-dependent protein kinase) kinases are the kinases involved in DNA damage 
sensing and signaling and are members of the phosphatidylinositol-3kinase-like kinase 
family (PIKKs).12 ATM and ATR further phosphorylate and activate the cell cycle 
regulating checkpoint kinases Chk1, Chk2 and MK2.13 In-vivo and in-vitro studies have 
suggested distinctive signaling by ATM and ATR based on the damage: ATM activated by 
DSBs and ATR to a wider variety of damages such as DSBs and DNA lesions causing 
replication stress. The ATM and ATR kinase are activated due to DNA polymerase stalling 
and DNA helicase activity related uncoupling due to strand breaks and lesions.12,14 Strand 
breaks have evidently shown leading to autophosphorylation of kinases and 
phosphorylating downstream proteins such as p53, mdm2, chk1, chk2, MK2, SMC1 which 
are involved in cell cycle regulation during replication.12,13 The outcome of which include 
cell cycle delay, DNA repair, replication fork stabilization, homologous recombination and 
cell survival. 
Furthermore, Replication Protein A (RPA) is a protein complex which recruits ATR-
ATRIP (ATR-interacting protein) complex to sites of strand breaks, stalled replication 
forks, stalled transcription complexes and DNA repair intermediates and acts as an 
important damage sensor for both repair and checkpoint regulation due to DNA damage.15 
Also, human 9-1-1 complex (three checkpoint proteins — Rad9, Rad1 and Hus1) with Rad-
17-RFC (Replication factor C) complex is phosphorylated after DNA damage and is shown 
to be recruited to sites of damage and further regulating the Serine/Threonine (ST) kinases 
– Chk1 and Chk-2.16 It was also found that in mammalian cells after UV irradiation, Chk1 
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was phosphorylated in an ATR-dependent manner whereas Chk2 was ATM-dependent.17,18 
In conclusion, the checkpoint specific damage sensors include ATM, ATR and the Rad17-
RFC/9-1-1 complex which regulates S/T kinases Chk1 and Chk2 important in downstream 
pathways for cell cycle regulation.16-18 
1.3 ACTIVE NER COMPLEX ESSENTIAL FOR ATR/ATM RECRUITMENT 
The Nucleotide Excision Repair (NER) pathway is involved in the removal of CPD and 
6-4PP removal after exposure to UVR. The GG-NER sub-pathway removes lesions from 
the entire genome whereas TC-NER sub-pathway removes lesions from the transcribed 
strand of active genes. In GG-NER, the CPD lesions are recognized by the damaged DNA 
binding proteins (DDBs) DDB1 and DDB2 and recruit XPC (Xeroderma pigmentosum 
complementation group C)-RAD23B complexes whereas 6-4PP are DDB independently 
recognized by XPC. Further XPC recruits the multi-protein NER complex of XPA, XPG 
and TFIIH which forms a bubble by opening the DNA helix around the lesions. XPA 
stabilizes the bubble while XPF and XPG endonucleases excise 24-32 bp oligonucleotide 
with the lesion and the gap is filled and the nick is ligated. Whereas in TC-NER, damage 
is sensed by CSA and CSB which recruit XPA and the NER complexes, therefore, making 
XPA an important component of both NER pathways.19,20 Additionally, experiments using 
G1 phase cells showed ATR and ATM recruitment is DDB, XPC and XPA dependent at 
the sites of UVR induced lesions which contributed to checkpoint signaling.19 
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Figure 3: Diagram of the TC-NER and GG-NER pathways.  
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1.4 ACTIVATION OF ATR-Chk1 AND ATM-Chk2 PATHWAYS 
The two main signaling pathways activated by DNA damage in vertebrates are ones 
involving ATM-Chk2 and ATR-Chk1 kinases. The ATM-Chk2 and ATR-Chk1 pathways 
are activated in response to different DNA damages. ATM-Chk2 is activated by DSBs 
whereas ATR-Chk1 is activated by replication stress due to lesions. Due to DSBs after 
exposure to UV, ATM is recruited and activates multiple substrates such as H2AX, MRN 
complex and SQ/TQ-rich motif of Chk2. Chk2 further acts on multiple substrates including 
p53 tumor suppressor protein involved in cell cycle progression, apoptosis and 
transcription.18 On the other hand, ATR-Chk1 is activated due to ssDNA formed due to 
blockage in replication by replication fork stalling caused by lesions or DSBs. Replication 
stalling leads DNA polymerase stalling which lead to long single strands of unwinding 
DNA. RPA and ATR-ATRIP complexes then get bound to this ssDNA.21 ATR activation 
and autophosphorylation22 further activate downstream Chk1 to initiate cell cycle arrest, 
restart stalling of replication fork by promoting DNA Repair.21 Though ATM and ATR 
activation process and downstream targets are different, they have partially overlapping 
targets like p53 and H2AX which is hugely dependent on the type of genotoxic stress.21 
For example: Chk1 activated by ATM after IR exposure.11 ATM is the principal mediator 
of G1 checkpoints in cell cycle and ATR mediates Intra S-Phase and G2/M Phase 
checkpoints but several studies have suggested a functional overlap between the two 
depending on the cell type and DNA damage.23,24 Hence defect or inhibition of either 
pathway could affect the downstream targets regulating the cell cycle. 
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Figure 4: The ATM/ATR DNA damage response pathway and its downstream effectors.  
Lapenna, Silvia and Antonio Giordano. “ Cell cycle kinases as therapeutic targets for 
cancer.” Nature reviews Drug discovery, vol 8, no.7, 2009, p 547+.Gale Academic 
onefile Accessed 27 August 2019. 
 
1.5 ATM-Chk2 AND ATR-Chk1 AS THERAPEUTIC TARGETS IN CANCER 
The main treatment strategy for cancer is Radiation and genotoxic chemotherapeutic 
agents which damage the DNA of cancerous tumor cells. The realization that these 
genotoxic agents activate the ATM-Chk2 and ATR-Chk1 pathways was the turning point 
in chemotherapeutic interventions to use inhibitors of these pathways to manipulate and 
make tumor cells more sensitive and susceptible to chemotherapy.27 This was confirmed 
by few studies in which ATM-deficient cells were radiosensitive and enhanced DNA 
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damage signaling showed resistance to radio and chemotherapy.28,29 The inhibition of Chk1 
using transfection or chemical inhibitors also showed higher cell toxicity to cancer cells 
when exposed to chemotherapeutic agents.30,31 Sensitization of ATM, ATR and other 
downstream kinases showed similar results.27,32 The pre-clinical proofs have encouraged 
pharmaceutical industries to undertake on-going clinical trials of few ATM and ATR 
inhibitors.33 
1.5 DNA DAMAGE TOLERANCE IN RESPONSE TO ssDNA 
During the process of DNA replication, replication of DNA damage can lead to fork 
collapses and genome instability and to avoid this the DNA damage tolerance (DDT) 
pathway is employed which bypasses the damages during replication and is repaired 
later. Hence, also known as the post replication repair (PRR). In mammals, DDT has 
two major pathways namely the Translesion synthesis (TLS) and Template Switching 
(TS). RPA coated ssDNA induces Ubiquitination of Proliferating cell nuclear antigen 
(PCNA), either mono or poly ubiquitination on lysine 164 (K164) which is a critical 
step in regulation of PRR.34 Mono-ubiquitination of PCNA recruits specialized TLS 
polymerases instead of DNA polymerase to site of stalled replication fork by promoting 
direct lesion bypass whereas poly-ubiquitination of PCNA promote damage avoidance 
by template switching with undamaged sister strand.35 As TLS polymerase has less 
fidelity, its error-prone and source of cellular mutagenesis whereas in TS there is 
temporary switch with undamaged sister strand for synthesis over the lesion which 
makes it error-free. RPA coated ssDNA is also involved  in ATR-CHK1 activation, and 
therefore is involved in both ATR-CHK1 as well as DDT pathways. Interestingly, 
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activation of CHK1 was associated with PCNA ubiquitination 34,35 which suggests 
possible crosstalk of DDT pathway with checkpoint regulators.  
1.6 ATM AND ATR ACTIVATION IN NON-REPLICATING CELLS 
The genotoxic agents used as chemotherapy have limited efficacy and is toxic not only 
to the cancer cells but also the normal cells in the body.27 The normal majority of cells in 
the human body are majorly quiescent, senescent or differentiated broadly termed as non-
replicating cells are also exposed to genotoxic agents like chemotherapeutics and other 
DNA damaging agents in the environment. ATM-Chk2 activation due to DSBs induced by 
transcription-blocking lesions was detected in postmitotic human neurons36 whereas ATR 
activation due to direct recognition of DNA lesions, ssDNA formation due to excision 
repair and transcription stress by RNA polymerase stalling were detected in mouse and 
human fibroblasts and keratinocytes.19,37-41 Though activation of these pathways was 
detected in non-replicating cells, the function of these pathways was unknown until 
recently, when experiments in Dr.Kemp’s lab revealed a pro-apoptotic function of ATR in 
response to UV and UV Mimetic exposure due to transcription stress in human 
keratinocytes. 
In this thesis, we further explore the activation and function of ATR in non-replicating 
keratinocytes and Human skin exposed to UVB radiation. 
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2 MATERIAL AND METHODS 
2.1 Cell culture: HaCaT keratinocytes were cultured in DMEM supplemented with 10% Fetal 
Clone III (Hyclone), 6 mM L-glutamine, 100 units/ml penicillin, and 100 µg/ml 
streptomycin. Telomerase-immortalized normal human foreskin keratinocytes (N-TERTs) 
were cultured in EpiLife medium containing human keratinocyte growth supplement 
(Thermo Fisher Scientific) and penicillin/streptomycin. All cells were maintained in a 5% 
CO2 humidified incubator at 37°C and monitored periodically for mycoplasma 
contamination (Sigma Venor GeM Kit). To generate non-replicating, quiescent cells, 
HaCaT cells were plated so that they would reach confluence in 2-3 days. Cells were then 
maintained for an additional 2 days in DMEM supplemented with 0.5% Fetal Clone III and 
penicillin/streptomycin. Quiescent N-TERTs were generated by growing the cells to 
confluence and then incubating for 2 days in basal EpiLife medium without any additional 
growth factors. Cells were treated with DMSO, the ATR inhibitor (ATRi) VE-821 
(Selleckchem or APExBio), triptolide (Sigma), spironolactone (APExBio), or THZ1 
(APExBio) for 30 min (or for 2 hr for spironolactone) prior to UVB exposure using a 
Philips F20T12 broadband UVB bulb at a dose rate of 5 J/m2/sec. 
2.2 Protein immunoblotting: Cells were scraped from the plate into cold PBS, pelleted, and 
lysed on ice in 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 
1% Triton X-100, and then soluble lysates were prepared by centrifugation at maximum 
speed in a microcentrifuge for 10-15 min. Chromatin-associated proteins were enriched 
from cells following three extractions with a modified cytoskeletal buffer (10 mM Tris-
HCl pH 7.4, 100 mM NaCl, 3 mM MgCl2, 1 mM EDTA, 1 mM Na3VO4, 10 mM NaF, and 
0.1% Triton X-100). Soluble and chromatin lysates were separated by SDS-PAGE and then 
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transferred to a nitrocellulose membrane. Blots were probed with 1:2000 dilutions of 
antibodies against phospho-KAP1 (Ser824; Bethyl A300-676A-M), phospho-p53 (Ser15; 
Cell Signaling 8284), phospho-CHK2 (Thr68; Cell Signaling 2621); phospho-ATR 
(Thr1989; GeneTex 128145), PCNA (Santa Cruz sc-10), or actin (Santa Cruz I-19) 
overnight in TBST (Tris-buffered saline containing 0.1% Tween-20). Chemiluminescence 
was visualized with either Clarity Western ECL substrate (Bio-Rad) or SuperSignal West 
Femto substrate (Thermo Scientific) using a Molecular Imager Chemi-Doc XRS+ imaging 
system. Signals in the linear range of detection were quantified using Image Lab (Bio-Rad) 
and normalized. 
2.3 DNA immunoblotting: Bromodeoxyuridine (BrdU) was added to a final concentration of 
10 µg/ml to the culture medium of proliferating or quiescent cells for either 15 min 
(HaCaT) or 30 min (N-TERT). Genomic DNA was purified using the GenElute 
Mammalian Genomic DNA Miniprep Kit (Sigma) and quantified using PicoGreen 
fluorescence (Invitrogen) using Synergy H1 Hybrid Multi-Mode microplate reader 
(BioTek). DNA was immobilized on nitrocellulose, dried, and immunoblotted for BrdU or 
cyclobutane pyrimidine dimers (CPDs).For CPDs, cells were harvested at the indicated 
time points following exposure to UV. The immunoblot blot method was similar to that 
described above with the exception that BrdU was omitted from the procedure and 250 ng 
of genomic DNA was immobilized on the nitrocellulose membrane. An anti-thymine 
dimer-HRP monoclonal antibody was used to detect CPDs presence and removal from 
genomic DNA. 
2.4 Cell survival: Acute cell survival was determined using crystal violet staining which was 
performed using 12-well and 3.5cm plates, and survival was typically determined 1-2 days 
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following treatment as indicated. Following removal of cell culture media and dead floating 
cells by aspiration and two washes with cold phosphate-buffered saline (PBS), the cells 
were fixed for 30–60 min in cold 100% methanol at −20 °C. Methanol was then aspirated 
and replaced with 0.5% crystal violet stain in 25% methanol for 10 min. The plates were 
then washed extensively in tap water to remove the excess stain. After drying, images of 
the stained cells were then taken on a Molecular Imager Chemi-Doc XRS+ system (Bio-
Rad) for the presentation of representative, qualitative results. The crystal violet stain was 
then solubilized in 1% SDS and the absorbance at 540 nm measured with a SpectraMax 
M3 spectrophotometer (Molecular Devices). The absorbance of the untreated sample was 
set to an arbitrary value of 1 for each experiment, and the treatment samples normalized to 
this value. Cell Survival was determined by MTT assay, in which methylthiazolyldiphenyl-
tetrazolium bromide (MTT) was added to the cell culture medium for 30 min before 
solubilization with DMSO and spectrophotometric detection at 550 nm. Cytotoxicity was 
measured with the Pierce LDH Cytotoxicity Assay Kit (ThermoScientific 88953). The 
proliferative capacity of quiescent HaCaT cells was determined by re-plating 100-200 cells 
5 days after treatment into normal DMEM containing 10% Fetal Clone III and for NTERTs 
10% of cell suspension were replated. Cells were allowed to grow and form colonies for 
10-14 days, after which cells were stained with crystal violet and counted. 
2.5 HPRT mutagenesis assay: HPRT mutagenesis assays were performed after quiescent 
cells were treated and were incubated for 5 days prior to plating and involved selection of 
UVB-irradiated HaCaT cells for 2 weeks with 6-thioguanine and the counting of resistant 
clones after crystal violet staining. 
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2.6 Ethynyl Uridine staining: The quiescent cells were grown on coverslips by placing them 
in 6-well plates and treatments with DMSO and VE-821 and UVB irradiation of 200 J/m2                                                                   
was done. The staining was done using Click-iT Nascent RNA capture kit C-10365 
wherein the active biomolecule was fed to cells to actively incorporate into RNA and then 
by using a chemoselective ligation Click reaction, the modified protein is detected using 
the reaction buffer kit. The nascent RNA pool in the cell was analyzed using Cytation 5 
Cell Imaging Multi-Mode Reader. 
2.7 Skin explant culture: Punch biopsy samples (8 mm) from de-identified human skin 
discarded during panniculectomy procedures were placed in hanging Millicell cell culture 
inserts (Millipore, Burlington, MA) in wells of a 24-well plate containing Epilife culture 
medium containing human keratinocyte growth factor. Patient consent for experiments was 
not required because de-identified, leftover surgical human tissue is considered to be 
discarded material by our institution, and thus the studies were exempt. Explants were kept 
in a 5% CO2 humidified incubator at 37 °C for up to 5 days after isolation. Experiments 
were initiated 1 day after beginning ex vivo culture, and medium containing the indicated 
compounds was changed daily. At the indicated time points, biopsy samples were snap 
frozen in liquid nitrogen or fixed in formalin. Sections were stained with hematoxylin and 
eosin to identify apoptotic, “sunburn” epidermal cells and counted using Cytation 5 Cell 
Imaging Multi-Mode Reader. For western blotting, epidermis from skin biopsies was 
scrapped and lysed in RIPA buffer with Protease/Phosphatase Inhibitor. Lysates were 
prepared by sonification and centrifugated at maximum speed following the steps in protein 
immunoblotting using Caspase-3 Rabbit monoclonal antibody (Cell signaling). 
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3 RESULTS 
3.1  In quiescent human keratinocytes, UVB exposure recruits XPB and activates 
ATR  
Quiescent keratinocytes were grown in-vitro by growing the replicating keratinocytes 
to confluence and then depriving them of growth factors. The quiescent state was 
confirmed by low incorporation of BrdU into genomic DNA as seen by 
immunoblotting in HaCaT and N-TERT keratinocytes. (Figure 5 A, B)  
To confirm the activation of ATR, quiescent keratinocytes were treated with DMSO or 
a small molecular inhibitor of ATR (ATRi) called VE-821 and were then exposed to 
UVB 200 J/m2 and harvested after 20 mins for western blotting. In quiescent HaCaT, 
ATR inhibition significantly reduced the expression of the DDR proteins KAP1, 
checkpoint kinase Chk2, downstream protein p53 as well as ATR autophosphorylation 
on-site Thr1989 after UVB exposure (Figure 5C, D). Similarly, in quiescent N-TERTs 
treated with VE-821, there was a significant decrease in UVB-induced KAP1 and p53 
activation. (Figure 5E, F) These results suggest that ATR is activated in response to 
UVB-induced DNA damage in quiescent keratinocytes. 
With reference to the study which showed that the ATR kinase activation in non-
replicating cells is due to transcription stress41 and another study demonstrating the role 
of DNA translocase and TFIIH component XPB by activation of ATR kinase in non-
replicating cells exposed to UV mimetic N-acetoxy-2-acetylaminofluorene (NA-AAF) 
which generated bulky DNA lesions,38 the role of XPB in ATR activation was 
evaluated in quiescent HaCaT exposed to UVB. The novel role of XPB in transcription, 
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transcription-coupled repair and NER after DNA damage in non-replicating cells was 
confirmed in the study using DNA translocase inhibitor triptolide (TPL), XPB 
degrading agent spironolactone (SP) and TFIIH dependent Cdk7 kinase inhibitor 
THZ1.38 Here we used the same inhibitors on quiescent HaCaT treated with 200 J/m2 
UVB and were harvested after 20 mins for western blotting. XPB depletion/inhibition 
significantly reduced the ATR kinase-dependent KAP1 and p53 activation after UVB 
exposure (Figure 5G, H). This result suggests that in human keratinocytes, transcription 
stress due to UVB exposure activates XPB subunit of TFIIH which is required for ATR 
activation. 
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Figure 5: ATR activation in quiescent keratinocytes is XPB dependent Immunoblot 
by BrdU labeling of genomic DNA to validate the quiescent state of (A) HaCaT and 
(B) N-TERTs. (C) Quiescent HaCaT cells treated with vehicle (DMSO) or the ATR 
inhibitor (ATRi) VE-821 were exposed to 200 J/m2 of UVB radiation and then 
harvested 20 min later for KAP-1, Chk2 and p53 phosphorylation and 4 hr later for 
ATR autophosphorylation. (D) Quantitation (average and SEM) of three independent 
experiments performed as in (C). (E) UVB-dependent activation of ATR kinase 
signaling in N-TERTs was analyzed and quantified (F) as described for HaCaT cells. 
(G) Quiescent HaCaT cells were treated with vehicle (DMSO), triptolide (TPL), 
spironolactone (SP), or the Cdk7 inhibitor THZ1 before exposure to 200 J/m2 of UVB. 
Cells were harvested 20 min later and analyzed by immunoblotting. (H) Quantitation 
(average and SEM) of three independent experiments performed as in (G). The 
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asterisks indicate that the level of protein phosphorylation is significantly different 
between the treatment groups (p<0.05).  
3.2 ATR kinase acutely protects quiescent human keratinocytes exposed to UVB. 
To confirm the pro-apoptotic function of ATR in non-replicating cells compared to pro-
survival function in replicating cells as shown in the study,42 the crystal violet cell 
survival assay was conducted using replicating HaCaT and quiescent HaCaT. Both 
types of cells were treated with vehicle DMSO and two different ATR Inhibitors VE-
821 and AZD6738 for 30 mins and then exposed to increasing low doses of UVB 
(Figure 6 A, B). Inhibition of ATR showed a decrease in relative survival which was 
UVB dose-dependent in replicating HaCaT whereas in quiescent HaCaT keratinocytes, 
ATR inhibition showed no effect on cell survival after UVB exposure. This result 
suggested that ATR could be playing a role in programmed cell death (ie. Apoptosis) 
of quiescent cells with DNA damage due to UVB exposure in replicating cells. To 
further explore the function of ATR in quiescent keratinocytes, MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assays were 
conducted in quiescent HaCaT and N-TERTs cells. ATR kinase inhibition did not 
sensitize the quiescent keratinocytes to UVB. (Figure 6 C, D) Further Analysis with 
the LDH Cytotoxicity assay showed that ATR inhibition significantly increased 
cytotoxicity in quiescent keratinocytes exposed to UVB. (Figure 6 E, F) These results 
with both HaCaT and N-TERT quiescent keratinocytes indicate that ATR kinase 
acutely protects the cells in the quiescent state from DNA damaging UVB radiation. 
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Figure 6: ATR kinase protects quiescent keratinocytes exposed to UVB. Crystal violet 
staining to compare cell viability in replicating (A) and non-replicating HaCaT cells (B) 3 
days after treatments with DMSO or ATR Inhibitors VE-821 or AZD6738 and exposed to 
UVB radiation. (C) HaCaT cells treated with DMSO or ATRi were exposed to UVB 
radiation, and cell viability was checked with MTT after a day. (D) Cytotoxicity was 
assessed in quiescent HaCaT cells as in (C) 1 day following UVB exposure using an LDH 
assay. (E) Cell survival and (F) cytotoxicity were measured 1 day after UVB exposure in 
N-TERT keratinocytes with MTT and LDH assays, respectively. 
3.3 ATR kinase is important for cell proliferation and protection against UV induced 
mutagenesis upon cell cycle re-entry. 
As ATR kinase showed acute protective effects with cell viability and toxicity 
assays, to further investigate the function of ATR kinase in a long term model when 
quiescent cells re-enter the cell cycle, we considered the clogenic survival assay. The 
quiescent keratinocytes were treated with vehicle DMSO or ATR inhibitor VE821 and 
were later stimulated with growth factors as described in the methods. (Figure 7A) The 
reason to conduct this experiment was to look at the effect of ATR inhibition when 
quiescent cells exposed to UVB were re-introduced the proliferative state. In HaCaT 
keratinocytes, inhibition of ATR showed a 3-6-fold decrease in colony formation. (Figure 
7B, C). As UVB exposure induces mutagenic lesions which could affect cell survival by 
causing mutations, we conducted the HPRT mutagenesis assay to investigate the role of 
ATR kinase in UVB induced mutagenesis (Figure 7A). The number of clones resistant to 
6-thioguanine were approximately 10 fold higher due to ATR inhibition in quiescent 
HaCaTs exposed to UVB (Figure 7D). 
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Whereas in N-TERTs to understand the role of ATR kinase long term function upon 
cell cycle re-entry, we considered the cell survival assay using crystal violet staining. 
Quiescent N-TERTs were treated with DMSO and VE821 and 10% of cell suspension were 
then re-plated after 3 days and allowed to grow in the presence of growth factors. (Figure 
7E) In N-TERTs, ATR inhibition showed a decrease in cell survival when re-introduced to 
the cell proliferation state. (Figure 7F).  
In conclusion, the results suggest that ATR kinase is important for cell cycle re-
entry for quiescent keratinocytes exposed to DNA damaging UVB radiation. It also has 
importance in repair and/or prevention of UVB induced mutagenesis. 
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Figure 7 ATR Inhibition decrease cell proliferation and increase mutagenesis upon 
cell cycle re-entry. (A) Design of an experiment to measure cell proliferation and 
mutagenesis upon stimulation of quiescent HaCaT keratinocytes with growth factors. (B, 
C) Clonogenic survival assays were initiated 5 days following the exposure of quiescent 
HaCaT cells to the indicated doses of UVB radiation in the presence of ATRi and Vehicle 
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(D) Quiescent HaCaT cells treated with DMSO or ATRi and exposed to 100 J/m2 UVB 
were selected with 6-thioguanine to quantify the number of cell clones with mutations at 
the HPRT locus. (E) Design of an experiment to measure cell proliferation in N-TERTs 
upon stimulation with growth factors. (F) Cell Survival Assay for quiescent N-N-TERTs 
exposed to UVB when re-introduced to the cell cycle in the presence of ATRi and vehicle. 
The asterisks indicate significant differences between the DMSO and ATRi treatment 
groups (p<0.05). 
3.4  Excision gap filling after NER in quiescent keratinocytes is dependent on error-
prone translesion DNA synthesis pathway after the loss of ATR kinase activity. 
UVB induced mutagenesis is due to the mutagenic DNA lesions CPDs and 6-4 PPs 
formed after UVB radiation. As ATR kinase inhibition showed increased mutagenesis 
in the HPRT assay, we further accessed if ATR inhibition affected the removal of the 
DNA lesions by the NER pathway. Immunodot blot analysis of genomic DNA of 
quiescent keratinocyte HaCaT exposed to UVB showed no significant difference in 
DNA lesion removal rate due to loss of ATR activity (Figure 8A). This confirmed that 
the mutagenesis due to ATR inhibition was not due to any defect in the activation of 
the NER pathway. 
Activation of NER to remove DNA lesions leads to ssDNA gaps in the genomic 
DNA which result in RPA and ATR dependent activation of checkpoints whereas in 
case of loss of ATR kinase activity, we suspected the activation of DNA damage 
tolerance pathway related error-prone mutagenic translesion synthesis (TLS) 
polymerases to promote gap filling and survival instead of canonical replicative DNA 
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polymerases.43,44 Mono-ubiquitination of PCNA is a signal for recruitment of TLS 
polymerases which was observed in quiescent HaCaT cells after UVB exposure, and 
ATR inhibition significantly increased the levels of PCNA and its mono-ubiquitinated 
forms. Moreover, RPA which binds to ssDNA in genomic DNA was significantly 
elevated with ATR inhibition (Figure 8 B, C). Hence, due to the loss of ATR kinase 
activity, there might be the formation of larger excision gaps and the gap filling after 
NER is TLS polymerases dependent which is promoting cell survival but with 
increased risk of mutagenesis.  
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Figure 8:  Loss of ATR activity potentiates activation of translesion DNA Synthesis. 
(A) Removal of cyclobutane pyrimidine dimers (CPDs) from genomic DNA of 
quiescent HaCaT cells exposed to 100 J/m2 UVB was measured by DNA 
immunoblotting. (B) Chromatin fractions of cells were isolated at the given time points 
following UVB exposure and analyzed by immunoblotting. Note that longer exposures 
using a stronger chemiluminescent substrate were used to detect PCNA mono-
ubiquitination. (C) The levels of chromatin-bound RPA, PCNA, and mono-
ubiquitinated PCNA were quantified from 3-5 independent experiments.  
3.5 ATR kinase is important for transcription recovery in quiescent cells with 
DNA damage 
To explore further the role of ATR kinase in quiescent human keratinocytes, 
experiment using 5-Ethynyl Uridine (EU) staining to determine the active pool of RNA 
was conducted. The Staining was done 30 mins and 6 hours after UVB irradiation of 
quiescent human keratinocytes treated with vehicle DMSO and ATR inhibitor to look 
for transcription recovery. Upon ATR inhibition, the quiescent keratinocytes did not 
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recover transcription efficiently (Figure 9 A, B). This could be either due to an impaired 
repair process, mutagenesis or checkpoint regulations. This also suggests that ATR 
kinase activity is important for transcription recovery after DNA damage. 
 
 
Figure 9: EU staining of quiescent HaCaT in absence and presence of ATR. (A,B) 
EU staining of quiescent HaCaT treated with DMSO and VE821 and exposed to UVB 
were fixed after 30 mins and 6 hour to determine RNA synthesis upon transcription 
recovery. 
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3.6 ATR kinase activity is important for apoptosis in human skin epidermis. 
Human skin is comprised of two layers of skin, the epidermis and the dermis. The 
epidermis is the outermost layer about 0.1 to 0.2 mm thick and is made of 4 types of 
cells namely, the keratinocytes which are 90% of the epidermal cell population, the 
Langerhans cells, melanocytes and Merkel cells. The human keratinocytes act like a 
protective barrier against environmental agents by activating and producing a number 
of proteins. These cells emanate from the deepest layers of the epidermis called stratum 
basale and undergo stages of cell differentiation and apoptosis before reaching the 
outermost layer called the stratum corneum consisting of dead cells.45 As UVB 
penetrates through the epidermal layer, the function of ATR kinase was investigated in 
human skin epidermal explants maintained in growth media. The epidermal explants 
were treated with vehicle DMSO and ATRi VE821 and exposed to UVB 1200 J/m2. 
Upon ATR inhibition, the cleaved caspase 3 signal was significantly reduced in 
epidermal skin exposed to UVB which suggest that ATR kinase is important in 
apoptotic signaling in the suprabasal human epidermal cells (Figure 10A). Further, we 
conducted H&E immunostaining to look at the effect of ATR inhibition on apoptotic 
“sunburn” cells (Figure 10B). ATR inhibition significantly reduced the number of 
sunburn cells on the epidermal layer which suggests that ATR kinase facilitates 
apoptosis in human skin epidermal cells. In conjugation with in-vivo studies which 
suggests that ATR kinase promotes cell survival, the ex-vivo experiment suggests that 
ATR kinase is involved in apoptosis of damaged human epidermal cells.   
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Figure 10: ATR activation in human skin epidermis. (A) Treatment of skin explant 
culture medium with the ATR inhibitor VE-821 partially blocks UVB-induced caspase 
3 cleavage (a marker of apoptotic signaling) in the epidermis. (B) H&E (Haemotoxylin 
and Eosin) staining was used to identify and quantify apoptotic “sunburn” cells in 
UVB-irradiated human skin epidermis after treatment with DMSO or the ATR kinase 
inhibitor VE-821. (C) H&E staining identified Sunburn cells. 
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DISCUSSION 
The role of ATR kinase activation and its functions in response to DNA damaging 
agents were established using cells which were actively replicating.12-20 The pro-survival 
role of ATR kinase and its inhibition was therefore considered as effective adjuvant therapy 
with chemotherapy to sensitize cancer cells and optimize chemotherapeutic effects.20,26-28 
On the contrary, ATR kinase activation was unexplored in non-cycling/replicating cells 
r4is exposed to harmful genotoxic environmental agents on a daily basis. Initial studies 
with non-replicating cell model using serum starved keratinocytes HaCaT gave us an 
insight that ATR kinase is activated in non-replicating cells when exposed to UV and UV 
mimetics. The ATR kinase activation in non-replicating cells was due to transcription stress 
and was suggested to have pro-apoptotic functions. 38,42 The contrast of replicating cells 
activating ATR in response to replication stress and exhibiting pro-survival functions 
compared to that in non-replicating cells which activated ATR in response to transcription 
stress and exhibiting pro-apoptotic function, therefore, confirmed the striking difference in 
the role of ATR kinase in both models. This convinced us to further investigate the role in 
non-replicating cell models to establish the opposing role ATR kinase could play wherein 
ATR inhibition could have different outcomes with cells in different cell proliferation state.  
   The developed model for our investigations was quiescent keratinocytes HaCaT 
and N-TERT. HaCaT is a p53 mutated immortalized keratinocyte cell line whereas N-
TERT is a telomerase reverse transcriptase immortalized keratinocyte cell line and both 
are widely used in research as alternative models. The cell lines were then grown to 
confluence and then kept in low serum (for HaCaT) and no serum (for N-TERT) to get into 
quiescence which was confirmed by BrdU incorporation in genomic DNA (Figure 5 A, B). 
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As different DNA damaging agents cause different types of DNA damages and lesions, we 
were curious to investigate ATR activation in response to UVB. The results with both 
quiescent keratinocyte cell types showed ATR activation when exposed to UVB and 
moreover was transcription stress induced. Similar to the study38 with UV Mimetic NA-
AAF, UVB induced damage activated ATR kinase in a TFIIH factor XPB dependent 
manner which implies that ATR activation was triggered due to RNA polymerase II stalling 
and activation of NER repair process in keratinocytes in a quiescent state. Also, the 
removal of DNA lesions via NER was not affected by the loss of ATR kinase activity and 
there was increased accumulation of RPA and PCNA on chromatin. Altogether, this could 
suggest that in quiescent keratinocytes, UVB induced DNA lesions are removed by NER 
and the resulting excision gaps activate ATR kinase which phosphorylates downstream 
kinases for repair. 
 After confirmation of ATR kinase activation in quiescent keratinocytes, next, we 
investigated its functions acutely and in the long term. Firstly, we conducted the MTT and 
LDH cell survival assays in both HaCaT and N-TERT quiescent keratinocytes exposed to 
different low and physiologically relevant doses of UVB. The results showed a slight 
decrease in cell viability when exposed to UVB in the absence of ATR whereas there was 
increased cytotoxicity in the same cellsa. Secondly, we conducted colony formation assay 
(for HaCaT) and crystal violet cell viability assay (for N-TERT) to look at the long-term 
effect of ATR inhibition in quiescent keratinocytes upon cell-cycle re-entry. In HaCaT, 
there was a decrease in colonies upon ATR inhibition and in N-TERT, the cell proliferation 
was decreased upon cell cycle re-entry due to ATR inhibition. Thirdly, the HPRT 
mutagenesis assay was conducted with quiescent HaCaT wherein upon cell cycle re-entry, 
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the colonies formed when treated with ATR inhibitor has higher mutations in the HPRT 
locus. In conclusion, the above experiments summarize that in quiescent keratinocytes 
exposed to UVB, ATR kinase plays an important role in cell survival by protecting against 
cytotoxicity. This ATR kinase protective role in survival also has implications in 
maintaining the cell proliferation and genomic integrity by preventing mutagenesis when 
resuming replication in the long term. Hence, ATR inhibition in quiescent keratinocytes 
could negatively impact the cell survival and increase the risk of mutagenesis when 
eventually resuming replication. 
 As discussed earlier, loss of ATR kinase activity did not affect the rate of NER 
process and therefore we suspected that error in gap filling could be the reason for the 
observed increase in mutagenesis. Significant increase in mono-ubiquitination of PCNA 
accompanied by increased RPA on ATR inhibition confirmed the activation of DNA 
Damage tolerance (DDT) pathway. The DDT pathway recruits TLS polymerases which 
have low fidelity in gap filling. Therefore, it can be said that the loss of ATR kinase in 
quiescent keratinocytes exposed to UVB activates the DNA Damage tolerance related TLS 
polymerases which are involved in mutations in HPRT locus. DNA sequencing or 
screening could give further insights into the mutation in the HPRT locus.  
 Experiments with ex-vivo human skin explants were also conducted to see the role 
of ATR kinase. As established with previous study 42 that ATR kinase has pro-survival 
functions, (Figure 10) the ex-vivo skin explants were analyzed for the pro-apoptotic 
function of ATR kinase. Inhibition of ATR kinase in human skin epidermis showed a 
decrease in the Caspase 3 signaling which is a major regulator of apoptosis. Moreover, the 
immunohistochemistry of Human skin epidermis showed a decrease in apoptotic 
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“Sunburn” cells caused due to DNA damaging UVB irradiation when treated with ATR 
inhibitor VE-821. Preliminary experiments with differentiated N-TERTs were conducted 
by us which showed a similar effect on apoptotic signaling by decreasing the PARP 
signaling when treated with ATR inhibitor and exposed to UVB. In conclusion, the in-vivo 
data using keratinocytes in quiescent state showed a pro-proliferative function of ATR 
kinase whereas ex-vivo data using epidermal keratinocytes isolated from human skin which 
majorly comprises of cells in differentiated showed a pro-apoptotic role of ATR kinase in 
response to UVB induced DNA Damage. As a balance between pro and anti-apoptotic 
signaling is essential for determining the fate of cells47, ATR inhibition affecting apoptotic 
signalling might be causing the dysregulation of this balance giving rise to malignancy. 
This could also mean that ATR inhibitors in chemotherapy might sensitize the cancerous 
cells to DNA damaging chemotherapeutic agents whereas the normal cells in the body 
which are in the quiescent and differtentiated state are protected during the treatment but 
are at high risk of mutagenesis and tumorigenesis upon cell-cycle re-entry. 
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APPENDIX 
6-4 PP – 6-4 Photoproducts 
ATM – Ataxia-telangiectasia mutated 
ATR – Ataxia-telangiectasia mutated and Rad 3-related 
ATR-ATRIP – ATR – interacting protein 
ATRi – ATR Inhibitor 
BER – Base excision Repair 
BrdU – Bromodeoxyuridine 
Chk1 – Checkpoint kinase 1 
Chk2- Checkpoint kinase 2 
CPD – Cyclobutene dimers 
CSA/CSB – Cockayne Syndrome proteins 
DDBs – Damaged DNA Binding proteins 
DDR – DNA Damage Repair 
DNA – De-oxy ribose nucleic acid 
DSBs – Double Strand Breaks 
EU- 5 ethynyl uridine 
GG-NER – Global genome Nucleotide excision repair 
H&E – Haemotoxylin and Eosin 
H2AX – Histone H2A X variant 
HPRT - hypoxanthine-guanine phosphoribosyltransferase 
HR – Homologous Recombination 
IR – Ionizing radiation 
KAP1 – KRAB-associated protein-1 
MMR – Mismatch Repair 
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NER – Nucleotide excision Repair 
NHEJ – Non – homologous end joining 
PCNA – Proliferating cell nuclear antigen 
PIKKs – Phosphoatidylinositol-3 kinase-like kinases 
RPA – Replication protein A 
SP – Spironolactone 
SsDNA – single-stranded DNA 
TC-NER – Transcription – coupled Nucleotide Excision Repair 
TFIIH – Transcription factor II H 
TLS – Translesion Synthesis 
TPL - Triptolide  
UVA – Ultraviolet Radiation A 
UVB – Ultraviolet Radiation B 
UVC – Ultraviolet Radiation C 
UVR – Ultraviolet Radiation 
XPB – Xeroderma pigmentosum complementation group B 
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